The PRebiotics Effect on Endotoxinemia in type 2 Diabetes

The PRebiotics Effect on Endotoxinemia in type 2 Diabetes - PREED

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000012234

Enrollment

Registered

2013-11-11

Start date

2013-12-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

type 2 Diabetes

Interventions

GOS placebo

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: type 2 diabetes treated over 3 months

Exclusion criteria

Exclusion criteria: patients prescribed alpha-GI and antibiotics

Design outcomes

Primary

Measure	Time frame
serum LBP,LPS	—

Countries

Japan

Contacts

Public ContactHiroko Kato

Kantoh Rosai Hospital diabetes and endoclinology

teamdm@kantoh.rofuku.go.jp044-411-3131

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026